The biotech sector continues to be mired in a tight trading range as we close out September, still digesting the nice gains from late in AugustIndividual small-cap names within the industry are still making big moves on company-specific newsIf you are a shareholder of Zogenix, Inc (ZGNX) , a name I have mentioned a few times over the years, you a...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.